TradingView
Kareim
Feb 14, 2018 10:32 PM

New Support Being Created 

描述

Despite failure at drug trials, stock still ranked "strong buy" by TipRank's 60th best rated analyst and others. May be a an opportunity to buy Call LEAP
更多